Haleon plc (HLN)

USD 9.71

(-2.02%)

Long Term Debt Summary of Haleon plc

  • Haleon plc's latest annual long term debt in 2023 was 8.8 Billion GBP , down -12.03% from previous year.
  • Haleon plc's latest quarterly long term debt in 2024 Q2 was 7.4 Billion GBP , down 0.0% from previous quarter.
  • Haleon plc reported annual long term debt of 10 Billion GBP in 2022, up 11397.7% from previous year.
  • Haleon plc reported annual long term debt of 87 Million GBP in 2021, down -17.14% from previous year.
  • Haleon plc reported quarterly long term debt of - GBP for 2024 Q1, down -100.0% from previous quarter.
  • Haleon plc reported quarterly long term debt of - GBP for 2023 Q3, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Haleon plc (2023 - 2019)

Historical Annual Long Term Debt of Haleon plc (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 8.8 Billion GBP -12.03%
2022 10 Billion GBP 11397.7%
2021 87 Million GBP -17.14%
2020 105 Million GBP -13.22%
2019 121 Million GBP 0.0%

Peer Long Term Debt Comparison of Haleon plc

Name Long Term Debt Long Term Debt Difference
Amneal Pharmaceuticals, Inc. 2.52 Billion USD -248.805%
Bausch Health Companies Inc. 21.93 Billion USD 59.887%
Catalent, Inc. 4.54 Billion USD -93.619%
Emergent BioSolutions Inc. 446.5 Million USD -1870.885%
Elanco Animal Health Incorporated 5.73 Billion USD -53.417%
Perrigo Company plc 3.63 Billion USD -142.237%
Teva Pharmaceutical Industries Limited 18.48 Billion USD 52.384%
Zoetis Inc. 6.56 Billion USD -34.065%